India’s initiatives to encourage the enforcement of regulations will be discussed by prominent industry experts at DIA India’s sixth Regulatory Conference, to be held in Ahmedabad, Gujarat. The two-day event from April 5-6, 2013 will bring together local and multinational pharmaceutical companies, clinical research professionals, academicians, regulators, and key stakeholders in health authorities to share the knowledge they’ve gained from decades of experience and note-worthy contributions to the development of the Indian pharma industry. The conference will feature Rajiv Gulati, President Global Pharmaceuticals Business, Ranbaxy Laboratories, speaking on the theme ‘India, the Upcoming Economy: Encouraging Enforcement of Regulations.’ Dr GN Singh from the Drug Controller General of India (DCGI) will also participate.
Programme co-chair, Dr Hemant Koshia, Food and Drug Commissioner of Gujarat, said, “DIA India’s sixth Regulatory Conference will focus on the challenge of keeping the Indian pharma industry competitive in the world market despite ever-evolving regulation. Attendees will discuss current issues in the regulatory field, deliberate how to be prepared to face up to these complexities by learning from the past, and decide proactive measures that could be taken by the industry.”
EP News Bureau – Mumbai
- Advertisement -
